Gagnon Robert E. 4
4 · Opus Genetics, Inc. · Filed Sep 11, 2025
Insider Transaction Report
Form 4
Gagnon Robert E.
Chief Financial Officer
Transactions
- Award
Common Stock
2025-09-10+200,000→ 200,000 total - Award
Employee Stock Option (right to buy)
2025-09-02+250,000→ 250,000 totalExercise: $1.23Exp: 2035-09-01→ Common Stock (250,000 underlying)
Footnotes (2)
- [F1]Represents a grant of restricted stock units which vest with respect to 25% on September 2, 2026, with the remaining shares vesting in equal monthly installments on the last day of each full month over the next thirty-six (36) months, subject to the Reporting Person's continuing service.
- [F2]The option will vest with respect to 25% on September 2, 2026, with the remaining shares vesting in equal monthly installments on the last day of each full month over the next thirty-six (36) months, subject to the Reporting Person's continuing service.